Self-assembling DNA quadruplex conjugated to MRI contrast agents

Jianfeng Cai, Erik M. Shapiro, Andrew D. Hamilton

Research output: Contribution to journalArticle

  • 22 Citations

Abstract

We report the preparation and magnetic resonance (MR) characterization of new MRI contrast agents based on gadolinium complexes conjugated to a self-assembling DNA quadruplex scaffold. As a single gadolinium-DOTA chelated DNA strand, the r1 molar relaxivity is 6.4 mM-1 s -1 per Gd and increases to 11.7 mM-1 s-1 per Gd upon formation of a DNA quadruplex. Similar results were obtained when a gadolinium-DOTA dendrimer was conjugated to DNA, with the r1 molar relaxivity increasing to 12.9 mM-1 s-1 per Gd upon the formation of DNA quadruplex, compared to that of 6.0 mM-1 s -1 for a single strand of gadolinium-DOTA dendrimer chelate. This yields an r1 molar relaxivity of 154.8 and 46.8 mM-1 s-1 per DNA quadruplex based on DOTA dendrimer or monomer, respectively. Importantly, the DNA quadruplex scaffold is approximately 2.5 nm3 in size, potentially enabling this type of contrast agent to be used for targeted delivery in vivo to detect specific cells or tissues, even behind intact blood vessels.

Original languageEnglish (US)
Pages (from-to)205-208
Number of pages4
JournalBioconjugate Chemistry
Volume20
Issue number2
DOIs
StatePublished - Feb 2009
Externally publishedYes

Profile

G-Quadruplexes
Contrast Media
DNA
Gadolinium
Dendrimers
Scaffolds
Magnetic resonance imaging
Blood Vessels
Magnetic Resonance Spectroscopy
Library Catalogs
Aerospace Medicine
Guanine Nucleotides
Blood vessels
Magnetic resonance
Monomers
Tissue

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Organic Chemistry
  • Pharmaceutical Science
  • Biomedical Engineering
  • Pharmacology

Cite this

Self-assembling DNA quadruplex conjugated to MRI contrast agents. / Cai, Jianfeng; Shapiro, Erik M.; Hamilton, Andrew D.

In: Bioconjugate Chemistry, Vol. 20, No. 2, 02.2009, p. 205-208.

Research output: Contribution to journalArticle

Cai, Jianfeng; Shapiro, Erik M.; Hamilton, Andrew D. / Self-assembling DNA quadruplex conjugated to MRI contrast agents.

In: Bioconjugate Chemistry, Vol. 20, No. 2, 02.2009, p. 205-208.

Research output: Contribution to journalArticle

@article{5e3b7177e2ef4837be7844c54c4d5b6c,
title = "Self-assembling DNA quadruplex conjugated to MRI contrast agents",
abstract = "We report the preparation and magnetic resonance (MR) characterization of new MRI contrast agents based on gadolinium complexes conjugated to a self-assembling DNA quadruplex scaffold. As a single gadolinium-DOTA chelated DNA strand, the r1 molar relaxivity is 6.4 mM-1 s -1 per Gd and increases to 11.7 mM-1 s-1 per Gd upon formation of a DNA quadruplex. Similar results were obtained when a gadolinium-DOTA dendrimer was conjugated to DNA, with the r1 molar relaxivity increasing to 12.9 mM-1 s-1 per Gd upon the formation of DNA quadruplex, compared to that of 6.0 mM-1 s -1 for a single strand of gadolinium-DOTA dendrimer chelate. This yields an r1 molar relaxivity of 154.8 and 46.8 mM-1 s-1 per DNA quadruplex based on DOTA dendrimer or monomer, respectively. Importantly, the DNA quadruplex scaffold is approximately 2.5 nm3 in size, potentially enabling this type of contrast agent to be used for targeted delivery in vivo to detect specific cells or tissues, even behind intact blood vessels.",
author = "Jianfeng Cai and Shapiro, {Erik M.} and Hamilton, {Andrew D.}",
year = "2009",
month = "2",
doi = "10.1021/bc8004182",
volume = "20",
pages = "205--208",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Self-assembling DNA quadruplex conjugated to MRI contrast agents

AU - Cai,Jianfeng

AU - Shapiro,Erik M.

AU - Hamilton,Andrew D.

PY - 2009/2

Y1 - 2009/2

N2 - We report the preparation and magnetic resonance (MR) characterization of new MRI contrast agents based on gadolinium complexes conjugated to a self-assembling DNA quadruplex scaffold. As a single gadolinium-DOTA chelated DNA strand, the r1 molar relaxivity is 6.4 mM-1 s -1 per Gd and increases to 11.7 mM-1 s-1 per Gd upon formation of a DNA quadruplex. Similar results were obtained when a gadolinium-DOTA dendrimer was conjugated to DNA, with the r1 molar relaxivity increasing to 12.9 mM-1 s-1 per Gd upon the formation of DNA quadruplex, compared to that of 6.0 mM-1 s -1 for a single strand of gadolinium-DOTA dendrimer chelate. This yields an r1 molar relaxivity of 154.8 and 46.8 mM-1 s-1 per DNA quadruplex based on DOTA dendrimer or monomer, respectively. Importantly, the DNA quadruplex scaffold is approximately 2.5 nm3 in size, potentially enabling this type of contrast agent to be used for targeted delivery in vivo to detect specific cells or tissues, even behind intact blood vessels.

AB - We report the preparation and magnetic resonance (MR) characterization of new MRI contrast agents based on gadolinium complexes conjugated to a self-assembling DNA quadruplex scaffold. As a single gadolinium-DOTA chelated DNA strand, the r1 molar relaxivity is 6.4 mM-1 s -1 per Gd and increases to 11.7 mM-1 s-1 per Gd upon formation of a DNA quadruplex. Similar results were obtained when a gadolinium-DOTA dendrimer was conjugated to DNA, with the r1 molar relaxivity increasing to 12.9 mM-1 s-1 per Gd upon the formation of DNA quadruplex, compared to that of 6.0 mM-1 s -1 for a single strand of gadolinium-DOTA dendrimer chelate. This yields an r1 molar relaxivity of 154.8 and 46.8 mM-1 s-1 per DNA quadruplex based on DOTA dendrimer or monomer, respectively. Importantly, the DNA quadruplex scaffold is approximately 2.5 nm3 in size, potentially enabling this type of contrast agent to be used for targeted delivery in vivo to detect specific cells or tissues, even behind intact blood vessels.

UR - http://www.scopus.com/inward/record.url?scp=62549093918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549093918&partnerID=8YFLogxK

U2 - 10.1021/bc8004182

DO - 10.1021/bc8004182

M3 - Article

VL - 20

SP - 205

EP - 208

JO - Bioconjugate Chemistry

T2 - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 2

ER -